Metadate

* Metadate CD (methylphenidate) extended release capsules was rated as better than previous ADHD treatments by 71% of patients in an open-label Phase IV clinical experience study. The study included patients previously treated by Alza Corp.'s Concerta and by immediate-release methylphenidate. 59% of patients rated Metadate better than Concerta, and 85% rated it better than immediate-release methylphenidate. 75% of the patients in the study said they would continue to use Metadate. Such studies are becoming an important part of pharmaceutical marketing strategies as patient satisfaction has proven to be a major factor in compliance with recommended therapies. Metadate is a product of Celltech Pharma Ltd. For more information contact Kelly Laban, Kovak-Likly Communications, (203) 762-8833, Klaban@KLCpr.com

COPYRIGHT 2003 Atlantic Information Services, Inc.
COPYRIGHT 2003 Gale Group